EdU |
5-Ethynyl-2′-deoxyuridine |
Bcl-2 |
B-cell lymphoma 2 |
CSRAs |
Cell culture chemotherapy sensitive and resistant assays |
CDXs |
Cell-Derived-Xenografts |
CRC |
Colorectal cancer |
dpf |
Days post-fertilization |
DBP |
Dynamic BH3 profiling |
EGFR |
Epidermal growth factor receptor |
ER |
Estrogen receptor |
ECM |
Extracellular matrix |
ESMO |
European Society for Medical Oncology |
FDA |
Food and Drug Administration |
HER2 |
Herceptin-2 |
HLA |
Human leukocyte antigen |
MOMP |
Mitochondrial Outer Membrane Permeabilization |
mPDX |
Mouse Patient-Derived Xenografts |
NCCN |
National Comprehensive Cancer Network |
PDXs |
Patient-Derived Xenografts |
PVS |
Perivitelline space |
pHH3 |
Phospho-histone H3 |
PARP |
Poly ADP ribose polymerase |
PD-1 |
Programmed cell death-1 |
prkdc |
Protein kinase DNA-activated catalytic polypeptide |
RMS |
Rhabdomyosacoma |
TME |
Tumor microenvironment |
zPDX |
Zebrafish Patient-Derived Xenografts |